Does RITUXIMAB-ABBS Cause Therapy non-responder? 39 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 39 reports of Therapy non-responder have been filed in association with RITUXIMAB-ABBS. This represents 0.9% of all adverse event reports for RITUXIMAB-ABBS.
39
Reports of Therapy non-responder with RITUXIMAB-ABBS
0.9%
of all RITUXIMAB-ABBS reports
33
Deaths
30
Hospitalizations
How Dangerous Is Therapy non-responder From RITUXIMAB-ABBS?
Of the 39 reports, 33 (84.6%) resulted in death, 30 (76.9%) required hospitalization, and 30 (76.9%) were considered life-threatening.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RITUXIMAB-ABBS. However, 39 reports have been filed with the FAERS database.
What Other Side Effects Does RITUXIMAB-ABBS Cause?
Off label use (2,167)
Intentional product use issue (273)
Dyspnoea (208)
Pain (205)
Rheumatoid arthritis (202)
Intentional dose omission (196)
Fatigue (195)
Drug ineffective (186)
Hypertension (183)
Infusion related reaction (183)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
Which RITUXIMAB-ABBS Alternatives Have Lower Therapy non-responder Risk?
RITUXIMAB-ABBS vs RITUXIMAB-ARRX
RITUXIMAB-ABBS vs RITUXIMAB-PVVR
RITUXIMAB-ABBS vs RIVAROXABAN
RITUXIMAB-ABBS vs RIVASTIGMINE
RITUXIMAB-ABBS vs RIVOTRIL